Artivion (AORT) Cash & Current Investments (2010 - 2026)
Artivion's (AORT) quarterly Cash & Current Investments came in at $55.8 million in Q1 2026, up 47.94% YoY from $37.7 million in Q1 2025, and down 14.09% on a QoQ basis from $64.9 million in Q4 2025.
Artivion (AORT) Cash & Current Investments (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Cash & Current Investments data on file, last reported at $55.8 million in Q1 2026.
- Quarterly Cash & Current Investments rose 47.94% year-over-year to $55.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.8 million (up 47.94% YoY) and the FY2025 annual result came in at $64.9 million, up 21.41% from the prior year.
- Cash & Current Investments declined to $55.8 million in Q1 2026, from $64.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $73.4 million in Q3 2025 to a low of $10.0 million in Q2 2022.
- A 5-year average of $48.9 million and a median of $53.5 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 80.35% — and 2023, when it soared 386.53%.
- Tracing AORT's Cash & Current Investments over 5 years: stood at $39.4 million in 2022, then soared by 49.78% to $58.9 million in 2023, then fell by 9.29% to $53.5 million in 2024, then rose by 21.41% to $64.9 million in 2025, then retreated by 14.09% to $55.8 million in 2026.
- The last three Cash & Current Investments figures came in at $55.8 million (Q1 2026), $64.9 million (Q4 2025), and $73.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn | 77.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.32 Mn |
| Mar 31, 2026 | 55.76 Mn |
| Dec 31, 2025 | 64.91 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Jun 30, 2025 | 53.48 Mn |
| Mar 31, 2025 | 37.69 Mn |
| Dec 31, 2024 | 53.46 Mn |
| Sep 30, 2024 | 56.17 Mn |
| Jun 30, 2024 | 55.02 Mn |
| Mar 31, 2024 | 51.12 Mn |
| Dec 31, 2023 | 58.94 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 48.78 Mn |
| Mar 31, 2023 | 30.77 Mn |
| Dec 31, 2022 | 39.35 Mn |
| Sep 30, 2022 | 37.57 Mn |
| Jun 30, 2022 | 10.03 Mn |
| Mar 31, 2022 | 51.41 Mn |
| Dec 31, 2021 | 55.01 Mn |
| Sep 30, 2021 | 65.13 Mn |